Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

  • There is currently no data for SNG

Synairgen News

AIM WINNERS & LOSERS: dotDigital plunges after profit warning
3 Mar 2022

AIM WINNERS & LOSERS: dotDigital plunges after profit warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Synairgen falls as trial for Covid treatment fails to meet endpoints
21 Feb 2022

Synairgen falls as trial for Covid treatment fails to meet endpoints

(Alliance News) - Synairgen PLC shares hit a 12-month low on Monday after the biotechnology company said that the late-stage trial of its Covid-19 tre...

AIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit
21 Feb 2022

AIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Synairgen shares plunge as Covid-19 treatment trial fails
21 Feb 2022

Synairgen shares plunge as Covid-19 treatment trial fails

(Sharecast News) - Synairgen announced on Monday that the international phase 3 trial of its SNG001 antiviral inhalation in patients hospitalised with...

IN BRIEF: Synairgen signs partnership for its Covid-19 treatment in US
6 Jan 2022

IN BRIEF: Synairgen signs partnership for its Covid-19 treatment in US

IN BRIEF: Synairgen signs partnership for its Covid-19 treatment in US

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal
11 Nov 2021

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal

Synairgen secures patients for phase III study of Covid treatment, shares jump
11 Nov 2021

Synairgen secures patients for phase III study of Covid treatment, shares jump

(Sharecast News) - Shares in Synairgen rallied on Thursday,after the respiratory drug specialist confirmed it was starting a Phase III study into a po...

IN BRIEF: Synairgen Covid treatment pushed for phase 3 trials by Activ
20 Oct 2021

IN BRIEF: Synairgen Covid treatment pushed for phase 3 trials by Activ

IN BRIEF: Synairgen Covid treatment pushed for phase 3 trials by Activ